Drilldown: Medicines
Appearance
Medicines > fda max
:
Indication-specific
or
~480 mg/d (oral); IV per protocol
& halflife:
~17-19 hours (longer than daridorexant) 
:
Indication-specific
or
~480 mg/d (oral); IV per protocol
& halflife:
~17-19 hours (longer than daridorexant) 
Use the filters below to narrow your results.
There are no results for this report.

